Colchicine treatment can be discontinued in a selected group of pediatric FMF patients.

Keren CohenShiri SpielmanRotem Semo-OzGuy BitanskyMaya GersteinYonatan YacobiAsaf VivanteIrit Tirosh

Published in: Pediatric rheumatology online journal (2023)

This study supports the concept of colchicine free remission in a minority of FMF patients (3%). Holding treatment, under close monitoring, may be reasonable when selecting the appropriate patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
young adults